ATP-sensitive K ϩ (K ATP ) channels couple cell metabolism to K ϩ channel activity (3) (4) (5) (6) (7) . K ATP channels are formed by four pore-forming subunits (Kir6.x) in association with four subunits of sulfonylurea receptors (8) , SUR1 or SUR2a/b. Kir1.1 has many properties similar to these K ATP channels and has been suggested to interact with the cystic fibrosis transmembrane conductance regulator or SUR2b to form a glibenclamide-sensitive and ATP-inhibited channel (9, 10) . Nucleotides can both inhibit and activate K ATP channels (3, 4, 11) . Inhibition of K ATP channel activity is mediated by binding of ATP to the Kir subunits, whereas channel activation by ADP occurs upon interaction with the SUR subunits. Phosphatidylinositol phosphates (e.g. phosphatidylinositol 4,5 diphosphate, PIP 2 ) 1 compete with ATP for gating of K ATP channels (12) (13) (14) (15) (16) . The effect of PIP 2 to antagonize the inhibitory action of ATP provides a mechanism for opening K ATP channels in intact cells in the presence of cytosolic ATP concentrations that would otherwise be inhibitory (13, 16 -18) .
We recently localized the ATP-binding region to the COOH terminus in each of the three ATP-regulated channels: Kir1.1, Kir6.1, and Kir6.2 (19) . We found that maltose-binding (MBP) fusion proteins containing Kir1.1 or Kir6.x COOH termini are efficiently produced in bacteria, are soluble without detergent, and directly bind TNP-ATP with a stoichiometry of at least one ATP per COOH-terminal monomer. In addition, we showed that phosphatidylinositol phospholipids competed for ATP binding to the COOH termini of Kir6.x and Kir1.1 channels (2), providing a mechanism for PIP 2 antagonism of ATP effects.
Kir1.1 or ROMK, originally cloned from rat kidney outer medulla (20) , forms the small conductance ATP-regulated K ϩ channel involved in apical K ϩ recycling in thick ascending limb and in K ϩ secretion in principal cells of the mammalian kidney (11) . Mutations in the human ROMK gene (Kcnj1) that cause loss of channel function give rise to Bartter's syndrome, which is characterized by volume depletion resulting from renal salt wasting (21, 22) . Mice with deletion of the ROMK (Kir1.1) gene exhibit a phenotype consistent with Bartter's syndrome with polyuria, increased urinary Na ϩ loss, and extracellular fluid volume depletion (23) . The ROMK-deficient mice have no small conductance channel activity on apical membranes of thick ascending limb or principal cells, consistent with ROMK encoding the small conductance K ϩ recycling/secretory channel in kidney.
In the present study, we further localized the ATP binding within the COOH terminus of Kir1.1. We assessed TNP-ATP binding and its antagonism by PIP 2 to purified maltose-binding fusion proteins with deletions of the cytosolic COOH terminus of Kir1.1. The ATP-PIP 2 binding domain was localized to the first 39 amino acids of the COOH terminus of Kir1.1. We also defined specific arginine residues within this 39-amino acid domain that are critical for TNP-ATP binding. Because these arginine residues are conserved in the Kir6.x channels, similar domains in these channels are likely to also form ATP-binding pockets. (19, 24) . The deletions and single amino acid substitutions in the COOH terminus of Kir1.1 were generated using PCR. All full-length and truncated Cterminal fragments of Kir1.1 included a stop codon and were ligated in-frame with MBP. All DNA constructs were verified by PCR and cycle sequencing (Keck Facility, Yale) and then transformed into Epicurian coli BL21-CodonPlus™-RIL competent cells (Stratagene, La Jolla, CA) for the protein expression.
MATERIALS AND METHODS

DNA
Production and Purification of Maltose-binding Fusion ProteinsRecombinant proteins were expressed as previously described by us (19) . Briefly, 1 liter of Luria-Bertani medium with 0.1 mg/ml ampicillin and 0.2% glucose was inoculated with 10 ml of an overnight culture of BL21 cells expressing the fusion vector and grown to an A 600 of ϳ0.5 at 37°C. Induction was performed with 0.3 mM isopropyl ␤-D-thiogalactoside at 37°C for 2 h. The cells were harvested and centrifuged at 4,000 ϫ g for 20 m at 4°C. The cell pellet was resuspended in 50 ml of Column Buffer (in mM: 20 Tris-HCl, 200 NaCl, 1 EDTA, pH 7.4) and frozen overnight at Ϫ20°C. The sample was thawed in ice water and lysed with a probe sonicator (4 times for 30 s, with 30-s intervals) in an ice-water bath. The sample was then centrifuged at 9,000 ϫ g for 30 min at 4°C. The supernatant was kept and diluted 1:5 with Column Buffer. The diluted extract was loaded into a 25-ml column containing 15 ml of amylose resin and washed with 12 column volumes of Column Buffer. The fusion protein was eluted with Column Buffer plus 10 mM maltose, and 1.5-ml fractions were collected. Protein was detected by UV absorbance at 280 nm, dialyzed against 50 mM Tris-HCl, pH 7.5, and kept at Ϫ80°C until experiments. All MBP fusion proteins were efficiently expressed, except for MBP_1.1C⌬180, and could be purified at milligram quantities (10 -25 mg/liter of bacterial culture) without exposure to detergents or denaturing agents. All MBP fusion proteins ran as single bands at their expected molecular masses on 10% PAGE gels.
TNP-ATP Binding-Binding of ATP to these recombinant fusion proteins was performed generally as described previously (19) . Briefly, 5 M recombinant protein was dissolved in 50 mM Tris-HCl at pH 7.5, and TNP-ATP binding was detected by the increase in fluorescence (Ex ϭ 403 nm; 546 nm; slit widths 5 nm) upon binding to recombinant protein using a Fluromax-3 spectrofluorometer (Jobin Yvon Inc., Edison, NJ). Temperature was maintained at 22 Ϯ 0.1°C by a circulating water bath (Neslab, Portsmouth, NH). Incremental additions of TNP-ATP were delivered to plastic cuvettes from stock solutions (0.2-1.0 mM). Protein was denatured by addition of 4 M urea where indicated.
The TNP-ATP fluorescence enhancement factor (␥) with binding to proteins, TNP-ATP to protein subunit stoichiometry (N), and dissociation constant (K d , M) were determined using a modified version of the binding equation derived by Faller (25) and as modified by us (19) using GraphPad PRISM™ 3.0 software. As seen in Equation I, observed fluorescence intensity (F obs ) in arbitrary units (a.u.) is given by
where P is the protein concentration (M). Q and Q 2 are constants (fluorescence intensity per M or M 2 of free TNP-ATP, respectively) derived independently from the concentration dependence of TNP-ATP fluorescence intensity in buffer alone (F Buffer ) and account for the inner filter effect (25) :
2 . Q c is the slope of the F Buffer versus (TNP-ATP) curve in buffer alone as shown in Equation 2 .
Protein light scatter intensity (F light scatter ) was subtracted from all F obs values. ␥ was measured at a fixed TNP-ATP concentration of 5 M by determining the increase in F obs with increasing protein concentration. The F obs data were fit well by a single exponential and F obs max was determined as F obs at infinite protein concentration when all TNP-ATP would be bound. The enhancement factor was then calculated as shown in Equation 3.
As shown in Equation 4, using individual ␥ values we calculated the concentrations of free (F) and bound (B) TNP-ATP as described by Moczydlowski and Fortes (26) .
(F) is then the difference between total (TNP-ATP) and (B). Bound versus free TNP-ATP plots were analyzed using a standard binding model that follows mass action as seen in Equation 5,
where B max is the maximal TNP-ATP binding. Data were also plotted for Scatchard analysis as described (19) . (Fig. 1) . However, truncation of 180 residues (MBP_1.1C⌬C180) dramatically reduced TNP-ATP fluorescence to below that for MBP_1.1C-WT. Because protein production was greatly reduced for MBP_1.1C⌬C180, further study of this construct was not performed. Finally, denaturing each of the MBP fusion proteins with 4 M urea significantly reduced the concentration-dependent TNP-ATP fluorescence increases (data not shown), consistent with TNP-ATP binding as described previously by us (19) .
RESULTS
Localization of the TNP-ATP Binding Segment in the
Fluorescence enhancement (␥) provides an index to the protein environment provided by the TNP-ATP binding pocket and generally correlates with binding affinity. ␥ values ( We also assessed the effects of truncations of the NH 2 -terminal end of the COOH terminus of Kir1.1 on the concentration dependence of TNP-ATP fluorescence (Fig. 3) . These deletions were from the initial region of the COOH terminus just distal to the second membrane-spanning segment. Recombinant MBP proteins with deletions from 10 -124 amino acid residues (MBP_1.1C⌬N10, MBP_1.1C⌬N25, MBP_1.1⌬N50, and MBP_1.1C⌬N124) that lack the first 10, 25, 50, and 124 amino acids of the COOH terminus, respectively, gave no significant TNP-ATP fluorescence increases (Fig. 3, A and B) . The MBP_1.1⌬N124 construct consists of the 84 amino acid residues deleted in the MBP_1.1⌬C84 construct shown in Fig. 1A . Thus, deletion of as few as 10 amino acid residues from the NH 2 -teminal end of the COOH terminus eliminated TNP-ATP binding.
We further examined TNP-ATP fluorescence increases with truncation of the NH 2 -terminal end of the MBP_1.1⌬C160 construct that binds TNP-ATP with high affinity (Figs. 1A and  2A) . The concentration-dependent TNP-ATP fluorescence in- creases were virtually abolished with deletion of the first 5 or 10 amino acids in MBP_1.1C⌬C160, MBP_1.1C⌬C160(⌬N5), or MBP_1.1C⌬C160(⌬N10), respectively (Fig. 3C) . Thus, the initial 5-10 amino acid residues of the COOH terminus of Kir1.1 are crucial for TNP-ATP binding in the entire COOH terminus as well as the 49-amino acid binding segment in MBP_1.1⌬C160.
To verify that the TNP-ATP binding domain is contained within the initial 39 amino acid residues of the COOH terminus of Kir1.1 (MBP_1.1C⌬C170), we assessed TNP-ATP fluorescence increases with MBP_1.1C⌬C170 compared with MBP_1.1C⌬N39 (Fig. 3D) . The latter construct represents the 170-amino acid segment of the COOH terminus following the initial 39 residues. As shown in Fig. 3D , TNP-ATP fluorescence increased significantly in a concentration-dependent manner with MBP_1.1C⌬C170 but not with MBP_1.1C⌬N39. Thus, the initial 39 amino acid residues of the Kir1.1 COOH terminus are sufficient to bind TNP-ATP with high affinity and contain the only TNP-ATP binding site in the Kir1.1 COOH terminus.
The Kinetics of TNP-ATP Binding to the Truncated COOH Terminus of Kir1.1-The ␥ derived from Equation 3 was used to calculate the protein-bound and free TNP-ATP concentrations according to Equation 4 as described in Ref. 19 . Plots of these data for MBP_1.1⌬C160 and MBP_1.1⌬C170 are shown in Fig. 4 , A and C, respectively. The data were generally well fit (r 2 ϭ 0.97 (Fig. 4A) and r 2 ϭ 0.95 (Fig. 4B) ; p Ͻ 0.01) by Equation 5 for a single binding-site model, although some points did deviate slightly from the curve. The reason for the slight deviations is not clear, although this may involve some cooperativity associated with protein-protein interactions in the multimeric forms of these proteins shown previously (1). K d values were similar to those determined from the F obs data in Fig. 4 , B and D, respectively. The Scatchard data were well fit by a linear non-competitive binding equation (19) as described by Moczydlowski and Fortes (26) and yielded kinetic parameters similar to those calculated from the bound versus free curves.
Mutation of Single Residues in the First 39 Amino Acids of the COOH Terminus Abolish TNP-ATP Binding-Mutation
of a number of residues in the COOH terminus of Kir6.2 have been shown to reduce sensitivity of this K ATP channel to ATP and/or PIP 2 (14, (27) (28) (29) . Because channel gating is a complex process involving at a minimum both the binding of ATP and the subsequent closing of the channel pore, we examined the effects of some of these mutations on TNP-ATP binding to MBP_1.1C⌬C170. We focused on four arginine residues, Arg 188 , Arg 203 , Arg 212 , and Arg 217 , in Kir1.1 (ROMK1) that are conserved in Kir6.x COOH termini ( (Fig. 6A) . Thus, for the other conserved arginine residues we assessed only the Arg to Ala mutations. TNP-ATP binding was markedly reduced in the MBP_1.1C⌬C170(R203A) and MBP_1.1C⌬C170(R217A) mutant constructs (Fig. 6, B and D, respectively) . In contrast, mutation of Arg 212 , MBP_1.1C⌬C170(R212A), had no significant effect on the concentration-dependence of TNP-ATP increases in F obs compared with MBP_1.1C⌬C170 (Fig. 6C) .
The ␥ for MBP_1.1C⌬C170(R212A) was significantly higher, whereas the K d was significantly lower than for (Fig. 7A, right panel) . PIP 2 reduced 10 M TNP-ATP F obs in MBP_1.1C⌬C170 in a concentration-dependent manner with an EC 50 of 10.9 Ϯ 0.2 M. Because TNP-ATP binding was unaltered in the MBP_1.1⌬C170(R212A) mutant construct (Fig. 6C) and mutation of a similar arginine residue to the Kir6.2 COOH terminus reduced PIP 2 gating sensitivity (14), we assessed the ability of PIP 2 to compete TNP-ATP binding in MBP_⌬C170(R212A). Using a similar protocol to that shown in Fig. 7A, Fig. 7B shows that PIP 2 reduced TNP-ATP binding to MBP_1.1⌬C170(R212A) with an EC 50 of 5.7 Ϯ 0.7 M (p Ͻ 0.001 compared with MBP_1.1⌬C170). Thus, the R212A mutation enhanced, rather than diminished, the ability of PIP 2 to compete TNP-ATP binding to MBP_1.1C⌬C170.
DISCUSSION
Our previous study provided direct evidence that TNP-ATP can bind to the COOH termini of Kir1.1 and the ATP-sensitive 
K
ϩ channels, Kir6.1 and Kir6.2 (19) . Because TNP-ATP did not bind to the NH 2 termini of Kir1.1 or Kir6.1, the COOH terminus of ATP-regulated K ϩ channels was both necessary and sufficient to bind nucleotides. The present observations support the suggestion that ATP inhibition of K ATP channel activity is mediated by interaction of ATP with the COOH terminus of the Kir subunit. Here we have further localized the nucleotide binding segment of Kir1.1 to the initial 39 amino acid residues of the COOH terminus. In addition, we show that specific residues within this segment are critical to nucleotide binding. Finally, we demonstrate that this 39-residue segment also retains the critical sequences necessary for PIP 2 competition of TNP-ATP binding.
Several lines of evidence indicate that the initial 39 amino acid residues of the COOH terminus of Kir1.1 is the minimal segment necessary for the high affinity binding of TNP-ATP and for PIP 2 competition and that this segment is the only significant adenine nucleotide-binding region along the COOH terminus of Kir1.1. First, MBP_1.1C⌬C170 bound TNP-ATP with higher affinity than the entire COOH terminus (Figs. 1  and 2, MBP_1.1C-WT) or any of the other truncation constructs (Figs. 1-4) . In addition, TNP-ATP binding to the construct with a 10-residue greater truncation (MBP_1.1C⌬C180) was dramatically reduced compared with MBP_1.1C⌬C170 (Fig. 1) . Moreover, MBP_1.1⌬C170 exhibited a significantly higher ␥ (Fig. 2C) than for MBP_1.1C-WT, consistent with an improved protein environment for TNP-ATP binding. Second, the 170-amino acid segment of the COOH terminus beyond the initial 39 amino acid residues (MBP_1.1C⌬N39) did not exhibit significant TNP-ATP binding (Fig. 3D) , demonstrating that nucleotide binding is limited to the first 39 amino acids of the COOH terminus. Third, truncations of as few as 5 amino acids from the NH 2 -terminal end of the COOH terminus (Fig. 3C) virtually abolished TNP-ATP binding. Fourth, mutation of any one of three individual residues (Fig. 6, Arg 188 , Arg 203 , or Arg 217 ) within the 39-amino acid MBP_1.1C⌬C170 construct abolished TNP-ATP binding, indicating that they are directly involved in the formation of the TNP-ATP binding structure of Kir1.1. The observation that R212A did not alter TNP-ATP binding (Fig. 6C) indicates that the effects of R188A (Fig. 6A) , R203A (Fig. 6B) , and R217A (Fig. 6D) Fig. 5 ) has been shown to alter channel gating by ATP and/or PIP 2 (14) . Because ATP and PIP 2 are competitive regulators of K ATP channel gating and we have shown that TNP-ATP and PIP 2 interactions occur within the same 39-amino acid segment (Fig. 7) , this mutational study in Kir6.2 is fully consistent with our observations of the critical roles of Arg 188 and Arg 217 in nucleotide binding (Fig. 6) . Interestingly, the R201A mutation in Kir6.2 (Fig. 5A) , corresponding to R212A in Kir1.1, reduces Kir6.2 channel gating by ATP and PIP 2 , whereas this mutation in Kir1.1 has no effect on TNP-ATP binding (Fig. 6C ) and enhances competition of TNP-ATP binding by PIP 2 (Fig. 7B) We previously suggested that TNP-ATP binds to the COOH termini of Kir1.1 and the Kir6.x ATP-sensitive channels with a stoichiometry of at least one molecule of ATP binding per COOH-terminal protein (19) . The TNP-ATP/protein stoichiometry of 0.78 for the entire Kir1.1 COOH terminus (MBP_1.1C-WT) confirms our previous observations of a single adenine nucleotide binding site for each of the four Kir subunits forming the kidney ATP-regulated K ϩ channel. The present results provide additional support for this model by demonstrating that TNP-ATP binding is confined to a single short segment in the COOH terminus of Kir1.1. Although the N o for MBP_1.1C⌬C170 (Fig. 2B ) was reduced compared with WT, the stoichiometry of 0.5 is still consistent with one binding site per protein molecule. The reduced stoichiometry was also observed in MBP_1.1C⌬C84 and MBP_1.1C⌬C160, suggesting that amino acids in the distal COOH terminus may be involved in the stabilization of the proximal 39-residue adenine nucleotide binding pocket.
One of the major regulatory mechanisms of Kir1. In summary, we have defined a 39-amino acid segment in the Kir1.1 (ROMK) COOH terminus that forms an ATP-PIP 2 binding domain and have identified three arginine residues that significantly alter TNP-ATP binding. Because this region is similar and the three critical arginine residues are conserved in Kir6.x channels (Fig. 5B) , it seems likely that the initial COOH-terminal segment in K ATP channels also forms an ATP-PIP 2 binding domain.
